Novel delivery device for monolithical solid oral dosage forms for personalized medicine.
There is an evident need for solid oral dosage forms allowing patients' tailor-made dosing due to variations in metabolization or small therapeutic indexes of drug substances. The objective of this work is the development of a device equipped with a novel solid dosage form, containing carvedilol as model drug, for the delivery of monolithical drug carriers in individual doses. The device was developed and constructed enabling an exact feed rate and dose adjustment by a cutting mechanism. A twin-screw extruder was used for producing cylindrical solid dosage forms. Divided doses were characterized by mass variation, cutting behavior and drug dissolution in order to investigate their applicability for practical use. Different formulations could be extruded obtaining straight cylindrical rods, which are divisible in exact slices by using the novel device. Forces below 20 N were needed to divide doses which comply with pharmacopoeial specification "conformity of mass". The developed formulations exhibit a sustained release of carvedilol within a range from 7 up to 16 h. A novel system consisting of a device and a cylindrical dosage form was developed. Patients' individual doses can be applied as monolithical solid dosage forms for oral use.
Wening
Klaus
K
Institute of Pharmaceutics and Biopharmaceutics, Heinrich-Heine-University, Universitaetsstr 1, 40225 Duesseldorf, Germany. klaus.wening@uni-duesseldorf.de
Breitkreutz
Jörg
J
D000284:Administration, Oral; D018674:Adrenergic Antagonists / Q000008:administration & dosage / Q000737:chemistry*; D002227:Carbazoles / Q000008:administration & dosage / Q000737:chemistry*; D000077261:Carvedilol; D002626:Chemistry, Pharmaceutical; D003692:Delayed-Action Preparations; D004304:Dosage Forms; D004337:Drug Carriers; D004339:Drug Compounding; D004867:Equipment Design; D005240:Feasibility Studies; D007700:Kinetics; D057285:Precision Medicine; D011412:Propanolamines / Q000008:administration & dosage / Q000737:chemistry*; D012995:Solubility; D013678:Technology, Pharmaceutical / Q000295:instrumentation / Q000379:methods
D018674:Adrenergic Antagonists; D002227:Carbazoles; D003692:Delayed-Action Preparations; D004304:Dosage Forms; D004337:Drug Carriers; D011412:Propanolamines; D000077261:Carvedilol